Manulife (Manufacturers Life Insurance)
PRLD icon

Manulife (Manufacturers Life Insurance)’s Prelude Therapeutics PRLD Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio PRLD Stock Details PRLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-70,546
Closed -$200K – 2893
2025
Q4 		$200K Buy
70,546
+1,294
+2% +$2.18K ﹤0.01% 2531
2025
Q3 		$99.7K Hold
69,252
– – ﹤0.01% 2780
2025
Q2 		$56.1K Hold
69,252
– – ﹤0.01% 2872
2025
Q1 		$53.2K Sell
69,252
-793
-1% -$740 ﹤0.01% 2821
2024
Q4 		$89.3K Hold
70,045
– – ﹤0.01% 2844
2024
Q3 		$145K Hold
70,045
– – ﹤0.01% 2767
2024
Q2 		$267K Sell
70,045
-2,217
-3% -$9.02K ﹤0.01% 2472
2024
Q1 		$343K Buy
72,262
+2,097
+3% +$8.16K ﹤0.01% 2335
2023
Q4 		$300K Hold
70,165
– – ﹤0.01% 2412
2023
Q3 		$217K Hold
70,165
– – ﹤0.01% 2556
2023
Q2 		$316K Buy
70,165
+35,867
+105% +$214K ﹤0.01% 2323
2023
Q1 		$195K Hold
34,298
– – ﹤0.01% 2578
2022
Q4 		$191K Buy
34,298
+31
+0.1% +$199 ﹤0.01% 2593
2022
Q3 		$224K Hold
34,267
– – ﹤0.01% 2512
2022
Q2 		$178K Hold
34,267
– – ﹤0.01% 2716
2022
Q1 		$238K Buy
+34,267
New +$313K ﹤0.01% 2650
2021
Q2 		– Sell
-5,516
Closed -$239K – 3273
2021
Q1 		$239K Buy
5,516
+227
+4% +$15.1K ﹤0.01% 2770
2020
Q4 		$378K Buy
+5,289
New +$263K ﹤0.01% 2376

Other funds holding PRLD

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s PRLD Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) sold out of Prelude Therapeutics (PRLD) in Q1 2026, closing a stake of 70,546 shares — an estimated $200K sold.

Manulife (Manufacturers Life Insurance) first reported a position in PRLD in Q4 2020 and held it in 18 quarters. The position peaked at $378K in Q4 2020. 55 funds tracked by Wall St. Rank hold PRLD as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) reported no remaining Prelude Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 70,546 Prelude Therapeutics shares in Q1 2026, an estimated $200K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Prelude Therapeutics in Q4 2020 and held it in 18 quarters.
  • Manulife (Manufacturers Life Insurance)'s Prelude Therapeutics position peaked at $378K in Q4 2020.
  • 55 funds tracked by Wall St. Rank held Prelude Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.